German Hypoparathyroidism Registry

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital Augsburg

About this trial

Chronic hypoparathyroidism is a rare condition in which the parathyroid glands do not make enough parathyroid hormone (PTH). PTH helps control the levels of calcium and phosphate in the blood. When there is not enough PTH, calcium levels can become too low and phosphate levels can become too high. This may cause symptoms such as tingling, muscle cramps, weakness, or other health problems.

The most common cause of chronic hypoparathyroidism is surgery in the neck area. It can happen after thyroid surgery, surgery on the parathyroid glands, or other operations in the neck.

At the moment, most patients are treated with calcium and vitamin D tablets. These treatments help control calcium levels, but they cannot fully replace the normal effects of PTH in the body. A medicine that contains a form of human PTH is available for some patients, but it is not yet the standard treatment for everyone.

This registry collects medical information and follows patients over time. Its aim is to better understand patients' symptoms, possible long-term health problems, treatments, and overall health. A group of patients who have had their thyroid removed but do not have hypoparathyroidism will also be included for comparison.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

diagnosis of chronic hypo- or pseudohypoparathyroidism > 6 months or diagnosis of pseudohypoparathyroidism

age >= 18 yrs.

residing in Germany

Written consent for patients capable of giving informed consent

Disqualifiers

Minors and patients with severe mental illnesses, or patients who are unable to provide written informed consent.

h/o thyroidektomy with thyroid hormone replacement

age >= 18 yrs.

residing in Germany

Trial population

Patients within the area of Augsburg and southern Germany

Trial design

Design model

Case-control

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

long-term comorbidities in hypoparathyroidism

compared with a controll group

Time frame
15 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University Hospital Augsburg

Lead sponsor

Wuerzburg University Hospital

Collaborator

Ascendis Pharma Endocrinology Division A/S

Collaborator